• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解可改变 ADHD 肥胖风险的健康行为。

Understanding health behaviors that modify the risk for obesity in ADHD.

机构信息

Department of Psychology, Children's Hospital of Los Angeles, Los Angeles, CA, United States.

Department of Psychiatry and Human Behavior, Center for Advancement of Youth, University of Mississippi Medical Center, Jackson, MS, United States.

出版信息

J Pediatr Psychol. 2024 May 16;49(5):372-381. doi: 10.1093/jpepsy/jsae018.

DOI:10.1093/jpepsy/jsae018
PMID:38516857
Abstract

OBJECTIVE

Research provides support for the associated risk of inadequate sleep duration, limited physical activity, and excessive media use in attention-deficit/hyperactivity disorder (ADHD) and obesity. The present study aims to (1) examine the association between ADHD and overweight or obese status (OW/OB); (2) comprehensively examine sleep duration, physical activity, and media use as potential moderators of OW/OB; and (3) examine the moderating effects of these health behaviors cross-sectionally by comparing medicated youth with ADHD, unmedicated youth with ADHD, and youth without ADHD.

METHODS

Data were acquired from the 2018 and 2019 National Survey of Children's Health, a nationally representative survey of caregivers conducted across the United States. The current study used data for youth 11-17 years old with a final sample size of 26,644. Hours of sleep, physical activity, and media use per day were dichotomized based on national recommendation guidelines for each health behavior (i.e., either meeting or not meeting guidelines).

RESULTS

The OW/OB prevalence rate was 7% greater among unmedicated youth with ADHD than among medicated youth with ADHD. Medicated youth with ADHD and peers without ADHD had similar OW/OB rates. Among medicated youth with ADHD, physical activity, sleep duration, and media use did not contribute to OW/OB risk after controlling for family poverty level. However, among unmedicated youth with ADHD, meeting sleep duration guidelines was linked to a lower OW/OB risk.

CONCLUSION

Overall, findings suggest that clinical providers and parents may wish to prioritize improved sleep duration in the management of OW/OB risk in youth with ADHD.

摘要

目的

研究为注意力缺陷多动障碍(ADHD)和肥胖症与睡眠不足、身体活动受限和过度使用媒体之间的相关风险提供了支持。本研究旨在:(1)检验 ADHD 与超重或肥胖状态(OW/OB)之间的关联;(2)全面研究睡眠时长、身体活动和媒体使用作为 OW/OB 的潜在调节因素;(3)通过比较患有 ADHD 的用药青年、患有 ADHD 未用药青年和无 ADHD 的青年,来检验这些健康行为的跨截面调节作用。

方法

数据来自 2018 年和 2019 年的全国儿童健康调查,这是一项针对美国全国范围内的护理人员进行的具有代表性的调查。本研究使用了年龄在 11-17 岁的青年的数据,最终样本量为 26644 人。根据每个健康行为的国家推荐指南(即,是否符合指南),将每天的睡眠时间、身体活动和媒体使用时间分为两类。

结果

与用药的 ADHD 青年相比,未用药的 ADHD 青年的 OW/OB 患病率高 7%。用药的 ADHD 青年和无 ADHD 的同龄人具有相似的 OW/OB 率。在用药的 ADHD 青年中,在控制家庭贫困水平后,身体活动、睡眠时长和媒体使用并不能增加 OW/OB 的风险。然而,在未用药的 ADHD 青年中,符合睡眠时长指南与 OW/OB 风险降低相关。

结论

总体而言,研究结果表明,临床医生和家长可能希望在 ADHD 青年的 OW/OB 风险管理中优先考虑改善睡眠时长。

相似文献

1
Understanding health behaviors that modify the risk for obesity in ADHD.了解可改变 ADHD 肥胖风险的健康行为。
J Pediatr Psychol. 2024 May 16;49(5):372-381. doi: 10.1093/jpepsy/jsae018.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.
4
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.针对5至18岁儿童注意力缺陷多动障碍(ADHD)的家长培训干预措施。
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3.
5
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.多不饱和脂肪酸(PUFA)治疗儿童和青少年注意缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD007986. doi: 10.1002/14651858.CD007986.pub3.
6
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.
7
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).哌醋甲酯治疗注意缺陷多动障碍(ADHD)儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
8
Adherence to 24-Hour Movement Guidelines and Behavioral Health in Children With Attention Deficit Hyperactivity Disorder in the United States.美国注意缺陷多动障碍儿童对24小时运动指南的遵循情况与行为健康
J Phys Act Health. 2025 Jul 10;22(9):1143-1152. doi: 10.1123/jpah.2024-0497. Print 2025 Sep 1.
9
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.速释型哌甲酯用于治疗成人注意力缺陷多动障碍(ADHD)
Cochrane Database Syst Rev. 2014 Sep 18(9):CD005041. doi: 10.1002/14651858.CD005041.pub2.
10
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.